Institutional-grade analytics, real-time data, and AI research tools — built for investors who think in decades, not days.
Higher long-end yields are giving big banks a margin tailwind again. But the real test this week is whether funding costs, credit quality, and loan demand are starting to eat the benefit.
Read more →
The S&P 500 has delivered double-digit returns through the first three quarters of 2026. Large-cap US stocks, as measured by the S&P 500, have outperformed Bitcoin, gold, European, and emerging market stocks year-to-date.
The Investment Committee debates how to navigate Q3 earnings and whether the market is expecting too much from the reports.
Fidelity's Denise Chisholm says technology stocks have undergone an unusually large valuation reset even as earnings expectations continue to rise, potentially leaving the sector positioned for further gains. She discusses why tech's roughly 30% multiple contraction may already reflect concerns about slowing AI and technology spending, and why historical data suggests a slowdown in tech capex doesn't necessarily mean a contraction.
Across 11 midterm years, the Russell 2000 averaged just a 0.5% gain and finished higher only 45% of the time. Four CME Group products can help manage small-cap risk into the midterms: E-mini Russell 2000 and Micro E-mini Russell 2000 futures for direct exposure; and E-mini S&P 500 and Micro E-mini S&P 500 futures to spread against Russell.
Wall Street is riding a record-high wave of positive corporate guidance and expanding profit margins led by energy and tech. Can it last?
Shipping and insurance costs for energy flows surge, OPEC, non-OPEC ministers say
The sector set to lead another quarter of corporate profit growth is
The S&P 500 bull market turns 4 and the index is holding above 7,800, so LPL Financial's Adam Turnquist breaks down the key levels to watch, from the 7,600 pullback zone to the 8,000 target. He also covers Nvidia, Microsoft, Citigroup and this week's big bank earnings, and whether to buy the breakout or wait for a dip.
The Wall of Worry (WOW) Index currently sits at 'Chasing Prices,' indicating this market advance has not yet reached greed or a major top. I would view a 7–10% market decline as a buying opportunity, not the start of a bear market.
Russia says it may export up to 3.5 million tons of diesel a month by year-end
Options traders bet on 30% rally in Snap
Oil markets were struggling on Monday to gauge how President Donald Trump's new declaration of an “energy ceasefire” between Russia and Ukraine might help mitigate a deepening global oil crisis as the Middle East conflict drags on.
The current bull market is four years old. The S&P 500 has climbed almost 120% since its closing low on Oct. 12, 2022, before the release of ChatGPT unleashed a frenzy on all things artificial intelligence.
Implied volatilities among the major asset classes declined across the board as the primary drivers of cross-asset volatility contagion, rates and oil, both eased. The VIX Index declined 0.5 pts w/w to 14.8 but underperformed skew by another 0.5 pts due to opportunistic positioning for downside convexity.
Stocks are off to a solid October start. The next few weeks will likely determine how they finish the year.
"When feasible, I generally think it's preferable to make smaller adjustments, and to do so relatively quickly, rather than to wait and risk needing a larger course correction," said Beth Hammack, president of the Cleveland Federal Reserve. Her comments come after Fed officials signaled in September meeting minutes that they could vote to raise rates again — but did not give a clear indication on when such a decision would come.
Ledger confirmed that one customer device contained an unauthorized hardware implant. The wallets came from an approved reseller in Southeast Asia, and analysts trace somewhere between $72 million and $93 million in losses.
Fed's Hammack backs restrictive policy, says better if it comes 'relatively quickly'
As more money flows toward AI software offerings, Salesforce could deepen its customer relationships while Adobe looks vulnerable, analysts say.
For most of the past year, investors have been trying to answer what seems like a fairly straightforward question: How can the stock market continue to rise when interest rates keep moving higher? The conventional answer is that interest rates simply do not matter as much as they used to.
MENLO PARK, Calif., Oct. 12, 2026 /PRNewswire/ -- Meta Platforms, Inc. (NASDAQ: META) announced today that the company's third quarter 2026 financial results will be released after market close on Wednesday, October 21st, 2026.
Tesla's Cybercab will make its first appearance in Europe at the Paris Motor Show this week. Elon Musk is trying to expand the company's footprint outside of the US.
Comprehensive cross-platform coverage of the U.S. market close on Bloomberg Television, Bloomberg Radio, and YouTube with Scarlet Fu, Hema Parmar, Carol Massar and Tim Stenovec. -------- More on Bloomberg Television and Markets Like this video?
TORRANCE, Calif., Oct. 12, 2026 (GLOBE NEWSWIRE) -- Navitas Semiconductor (Nasdaq: NVTS), a leader in next-generation power semiconductors and power delivery solutions, pioneering GaN, high-voltage and ultra-high-voltage SiC, and IVR technologies, today announced its latest 24 kW, 800 V-to-12 V DC-DC power delivery board (PDB), powered by GaNFast™ technology and developed in collaboration with NVIDIA, to support the NVIDIA MGX ecosystem and advance 800 VDC power architectures for AI data centers.
New prespecified analyses showed consistent findings across clinically important and difficult to treat subgroups, including patients with prior biologic exposure Findings build on first positive results where TREMFYA achieved combined fistula remission rates of up to 28% across dosing groups Results come from the first dedicated Phase 3 randomized, placebo-controlled trial in adults managing Crohn's disease with perianal fistula in more than 20 years SPRING HOUSE, Pa., Oct. 12, 2026 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced new Phase 3 data showing consistent combined fistula remission outcomes with TREMFYA® (guselkumab) across clinically important subgroups of adults with Crohn's disease with perianal fistula.1 The prespecified subgroup analyses from the FUZION study are being presented at the American College of Gastroenterology (ACG) 2026 Annual Scientific Meeting and build on previously reported Week 24 results from the overall study population.
MIAMI--(BUSINESS WIRE)--Palantir Technologies Inc. (NASDAQ: PLTR) announced today that results for its third quarter ended September 30, 2026 will be released on Monday, November 2, 2026, following the close of U.S. markets. Palantir will host a webcast to discuss its results at 5:00 PM ET. A live webcast and replay will be available at investors.palantir.com, and participants can pre-register here. In addition, shareholders can submit and vote on questions by visiting https://app.saytechnologi.
New long-term data showed clinical remission rates of up to 94% and endoscopic remission rates of up to 61% in adults with moderately to severely active Crohn's disease 88% of patients achieved 90-day corticosteroid-free clinical remission SPRING HOUSE, Pa., Oct. 12, 2026 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced new three-year data from the Phase 3 GALAXI 2 and 3 studies showing durable efficacy and a consistent safety profile for TREMFYA® (guselkumab) in adults with moderately to severely active Crohn's disease.1 The Week 144 long-term extension (LTE) results being presented at the American College of Gastroenterology (ACG) 2026 Annual Scientific Meeting reveal long-term clinical and endoscopic outcomes across both TREMFYA maintenance regimens in this chronic disease.
The company's stock was up more than 3% following the release of Muse Wonder and Muse Wonder Full, which analysts expect to drive new business opportunities.
Tokenization has been one of asset management's loudest buzzwords for years. Yet most firms are still watching from the sidelines.
AMD's 2026 rally has made the stock too expensive to own. Nvidia is one of the more undervalued stocks in the market.